Belite Bio, Inc Stock Analysis & AI Score
Belite Bio, Inc (BLTE) has an ST Score of 63.8 (B), driven by its Financial Strength (A+) and held back by its Growth (C-). Analysts rate it Buy with a $245.83 price target (+45.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Belite Bio, Inc (BLTE) has an ST Score of 63.8 (B), driven by its Financial Strength (A+) and held back by its Growth (C-). Analysts rate it Buy with a $245.83 price target (+45.1% upside).
- Strongest
- Financial StrengthA+
- Weakest
- GrowthC-
All factor grades
- Financial StrengthA+
- MomentumA+
- ProfitabilityA
- ForecastB
- ValuationB-
- GrowthC-
- Piotroski2/9
Contact
BLTE stock: frequently asked questions
What is BLTE's ST Score?
Belite Bio, Inc (BLTE) has an ST Score of 63.8 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BLTE a buy, hold, or sell?
Analysts rate BLTE a Buy, with a price target of $245.83 (+45.1% vs the current price). Our ST Score grades it B (63.8/100). The ST Score is a data-driven signal, not a recommendation.
What are BLTE's factor grades?
Valuation B-, Profitability A, Financial Strength A+, Momentum A+, Growth C-, Forecast B.
What is BLTE's valuation grade?
Belite Bio, Inc (BLTE) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BLTE's growth grade?
Belite Bio, Inc (BLTE) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BLTE's profitability grade?
Belite Bio, Inc (BLTE) earns a profitability grade of A, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BLTE's financial strength grade?
Belite Bio, Inc (BLTE) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BLTE?
The average analyst price target for Belite Bio, Inc (BLTE) is $245.83 from 6 analysts, which is +45.1% versus the recent price of $169.44.
What is BLTE's Piotroski score?
Belite Bio, Inc (BLTE) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.